Compare Medpace Holdings Inc (MEDP) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Nuwellis Inc — how do they compare? Medpace Holdings Inc trades at $598.57 (market cap $16.90B), while Nuwellis Inc trades at $1.45 (market cap $542.80K). The key difference: Medpace Holdings Inc is far larger — about 31134.9× Nuwellis Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| MEDP | NUWE | |
|---|---|---|
Market Cap | $16.90B | $542.80K |
Sector | Technology | Technology |
52-Week High | $620.59 | $220.50 |
52-Week Low | $393.42 | $1.42 |
Enterprise Value | $16.52B | -$1.27M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
